These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14612920)
1. Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. Meschini S; Marra M; Calcabrini A; Federici E; Galeffi C; Arancia G Int J Oncol; 2003 Dec; 23(6):1505-13. PubMed ID: 14612920 [TBL] [Abstract][Full Text] [Related]
2. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells. Meschini S; Condello M; Marra M; Formisano G; Federici E; Arancia G Toxicol In Vitro; 2007 Mar; 21(2):197-203. PubMed ID: 17070665 [TBL] [Abstract][Full Text] [Related]
4. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance. Condello M; Pellegrini E; Multari G; Gallo FR; Meschini S Toxicol In Vitro; 2020 Jun; 65():104819. PubMed ID: 32135239 [TBL] [Abstract][Full Text] [Related]
5. The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells. Meschini S; Condello M; Calcabrini A; Marra M; Formisano G; Lista P; De Milito A; Federici E; Arancia G Autophagy; 2008 Nov; 4(8):1020-33. PubMed ID: 18838862 [TBL] [Abstract][Full Text] [Related]
6. Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts. Condello M; Cosentino D; Corinti S; Di Felice G; Multari G; Gallo FR; Arancia G; Meschini S J Nat Prod; 2014 Apr; 77(4):855-62. PubMed ID: 24720452 [TBL] [Abstract][Full Text] [Related]
7. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. Pellegrini E; Multari G; Gallo FR; Vecchiotti D; Zazzeroni F; Condello M; Meschini S Toxicol Appl Pharmacol; 2022 Jan; 434():115816. PubMed ID: 34856211 [TBL] [Abstract][Full Text] [Related]
8. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate. Leontieva OV; Preobrazhenskaya MN; Bernacki RJ Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193 [TBL] [Abstract][Full Text] [Related]
9. High-performance thin-layer chromatography for the evaluation of voacamine intracellular concentration related to its cytotoxic effect. Condello M; Multari G; Gallo FR; Arancia G; Meschini S J Pharm Biomed Anal; 2015 Nov; 115():467-74. PubMed ID: 26298394 [TBL] [Abstract][Full Text] [Related]
10. Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells. You M; Ma X; Mukherjee R; Farnsworth NR; Cordell GA; Kinghorn AD; Pezzuto JM J Nat Prod; 1994 Nov; 57(11):1517-22. PubMed ID: 7853002 [TBL] [Abstract][Full Text] [Related]
11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
12. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981 [TBL] [Abstract][Full Text] [Related]
15. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167 [TBL] [Abstract][Full Text] [Related]
16. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
18. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry. Sebille S; Morjani H; Poullain MG; Manfait M Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978 [TBL] [Abstract][Full Text] [Related]
19. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo). Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284 [TBL] [Abstract][Full Text] [Related]
20. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents. Jachez B; Loor F Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]